BUSINESS CASE | Transparency policy 0070

April 8, 2024

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070 for a new active substance on the Centralized Procedure (CP) registration.

Thanks to our extensive track record of over 20 years, at Asphalion we can assist you in selecting the optimal strategy, optimizing costs and enhancing time-to-market, as well as with all other kind of activities and projects.

CASE STUDY ANALYSIS: BUSINESS CASE TRANSPARENCY POLICY 0070 Asphalion

For further information you can contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

PragmaTIL | Second Annual Meeting

Asphalion expert Núria García participated last week in the 2nd Annual PragmaTIL Consortium Meeting in Amsterdam, hosted by the Netherlands Cancer Institute (NKI). This two-day

EVENT | RAPS EuroConvergence 2025

At ASPHALION we are pleased to announce our participation in RAPS EuroConvergence 2025, one of the premier regulatory affairs events in Europe. This year’s conference

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting